Indication:
This product is indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents in patients aged 6 years and older with a body weight of at least 15 kg.
Limitations of Use：
•Due to the risk of kernicterus, atazanavir sulfate capsules are not recommended for use in pediatric patients younger than 3 months of age.
•In patients with prior atazanavir/ritonavir treatment experience, treatment should be guided by the number of baseline major protease inhibitor resistance mutations.
Category:
Antiinfectives for Systemic Use
Generic Name:
Atazanavir Sulfate Capsules
Brand Name (Trademark):
洛美茵®
Strength:
200mg、300mg
